Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia.

Summary: High cholesterol isn't just about clogging arteries; it also involves inflammation and "sticky" blood platelets that can lead to clots. In this study, researchers compared two popular statins—Atorvastatin and Rosuvastatin—to see if one was better at calming these dangerous side effects. They also checked if a patient's specific genetics (LOX-1 gene) changed how well the drugs worked.

The verdict? Both drugs performed equally well. After eight weeks, patients on either medication saw significant drops in bad cholesterol, inflammation, and markers of clotting stress. Furthermore, a patient's genetic profile didn't matter—the drugs provided the same protective benefits regardless of the specific gene variant tested.